Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Albany Molecular Res (AMRI)

Albany Molecular Res (AMRI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 937,429
  • Shares Outstanding, K 43,120
  • Annual Sales, $ 570,450 K
  • Annual Income, $ -70,170 K
  • 60-Month Beta 1.17
  • Price/Sales 1.64
  • Price/Cash Flow N/A
  • Price/Book 2.95
Trade AMRI with:
  • Price/Earnings ttm 24.43
  • Earnings Per Share ttm 0.57
  • Most Recent Earnings 0.13 on 05/09/17
  • Next Earnings Date 09/07/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/17
See More
  • Average Estimate 0.23
  • Number of Estimates 1
  • High Estimate 0.23
  • Low Estimate 0.23
  • Prior Year 0.32
  • Growth Rate Est. (year over year) -28.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.52 +1.02%
on 08/01/17
21.78 -0.18%
on 08/11/17
unch (unch)
since 07/31/17
3-Month
19.44 +11.83%
on 06/01/17
22.17 -1.94%
on 06/05/17
+2.28 (+11.72%)
since 05/31/17
52-Week
13.01 +67.10%
on 03/23/17
22.17 -1.94%
on 06/05/17
+7.14 (+48.90%)
since 08/26/16

Most Recent Stories

More News
AMRI Becomes Curia

Albany Molecular Research, Inc. (AMRI), a leading global contract research, development and manufacturing organization serving the pharmaceutical and biopharmaceutical industries, today announced that...

AMRI : 21.74 (unch)
AMRI Celebrates 30th Anniversary

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, celebrates 30 years since its incorporation in Albany, New York....

AMRI : 21.74 (unch)
AMRI Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced expanded access to its accelerated solutions platform,...

AMRI : 21.74 (unch)
Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

VANCOUVER, BC, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first...

AMRI : 21.74 (unch)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Reports Fourth Quarter and 2020 Year End Results and Operational Update

Willow Biosciences Reports Fourth Quarter and 2020 Year End Results and Operational Update

AMRI : 21.74 (unch)
CANSF : 0.7106 (-1.52%)
AMRI Earns Spot on Forbes America's Best Employers 2021 List

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that the company is named on "America's Best Mid-Sized...

AMRI : 21.74 (unch)
AMRI Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that the company has been chosen to support the...

AMRI : 21.74 (unch)
AMRI Appoints Scott Waldman to Lead Corporate Development

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced the appointment of Scott Waldman as senior vice...

AMRI : 21.74 (unch)
AMRI Wins 2021 CMO Leadership Awards

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced it has been recognized in the 2021 CMO Leadership...

AMRI : 21.74 (unch)
AMRI Included in BARDA CDMO Network in Support of COVID-19 Pandemic Response in the U.S.

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced its Albuquerque, New Mexico, facility has been...

AMRI : 21.74 (unch)

Business Summary

Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 21.77
1st Resistance Point 21.76
Last Price 21.74
1st Support Level 21.73
2nd Support Level 21.71
3rd Support Level N/A

See More

52-Week High 22.17
Last Price 21.74
Fibonacci 61.8% 18.67
Fibonacci 50% 17.59
Fibonacci 38.2% 16.51
52-Week Low 13.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar